Reversal of left ventricular hypertrophy by propranolol in hypertensive rats

Charles I Maina1, Maurice Ogunde

  • 1Department of Zoology, Egerton University, P.O. Box 536, Njoro, Kenya. cimaina@yahoo.com

Insights

Propranolol effectively reversed left ventricular hypertrophy in hypertensive rats. This beta-blocker treatment also successfully lowered elevated systolic blood pressure, offering a potential therapeutic strategy.

Area of Science:

  • Cardiology
  • Pharmacology
  • Animal Models

Background:

  • Hypertension is a major risk factor for left ventricular hypertrophy (LVH).
  • Left ventricular hypertrophy is linked to an increased risk of sudden cardiac death.
  • Effective management of hypertension is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the potential of propranolol in reversing left ventricular hypertrophy in a rat model of hypertension.
  • To assess the impact of propranolol on blood pressure and cardiac structure.

Main Methods:

  • Hypertension was induced in male albino rats using a 1% NaCl solution.
  • Propranolol was administered orally to a subset of the hypertensive rats.
  • Systolic blood pressure was monitored using a tail-cuff method, and left ventricular geometry was analyzed post-mortem.

Main Results:

  • High salt intake led to increased systolic blood pressure and left ventricular hypertrophy.
  • Propranolol treatment normalized elevated systolic blood pressure from 139.4 +/- 0.5 mm Hg to 108.4 +/- 0.2 mm Hg.
  • Analysis of left ventricular weight, thickness, and volume indicated reversal of hypertrophy.

Conclusions:

  • Propranolol demonstrates efficacy in reversing left ventricular hypertrophy in hypertensive rats.
  • The study confirms propranolol's ability to lower elevated blood pressure in this model.
  • These findings support propranolol as a potential therapeutic agent for hypertension-induced cardiac remodeling.
Abstract